Arcus Biosciences Inc. (RCUS)
NYSE · Healthcare
Arcus Biosciences Inc. Revenue 2017–2025
Arcus Biosciences Inc. annual/quarterly revenue history and growth rate from 2017 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Arcus Biosciences Inc. revenue for the quarter ending March 31, 2026 was 7.0 M, a 12.50% decrease year-over-year.
- Arcus Biosciences Inc. revenue for the twelve months ending March 31, 2026 was 29.0 M, a 51.67% decrease year-over-year.
- Arcus Biosciences Inc. annual revenue for 2025 was 33.0 M, a 35.29% decrease from 2024.
- Arcus Biosciences Inc. annual revenue for 2024 was 51.0 M, a 37.84% increase from 2023.
- Arcus Biosciences Inc. annual revenue for 2023 was 37.0 M, a 2.63% decrease from 2022.
- Arcus Biosciences Inc. annual revenue for 2022 was 38.0 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Arcus Biosciences Inc. Revenue — FAQ
Arcus Biosciences Inc. (RCUS) revenue over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
What is Arcus Biosciences Inc.'s revenue?
Arcus Biosciences Inc. (RCUS) reported revenue of $33M for fiscal 2025.
Where can I see RCUS's revenue history?
The chart and table above show Arcus Biosciences Inc.'s revenue by year and by quarter, including the growth rate.